CONVERSION AGREEMENTConversion Agreement • June 25th, 2024 • Provectus Biopharmaceuticals, Inc. • Pharmaceutical preparations
THIS CONVERSION AGREEMENT (this “Agreement”) is entered into as of June 21, 2024 (the “Agreement Date”) by and between Provectus Biopharmaceuticals, Inc., a Delaware corporation (“Provectus”), and Dominic Rodrigues, an individual stockholder, director and officer of Provectus (the “Stockholder”). Provectus and the Stockholder are collectively referred to herein as the “Parties” and individually as a “Party”.
